Secondary Logo

Journal Logo

Penile cancer

Providing patient support

doi: 10.1097/01.NURSE.0000532039.52354.7f
CE Connection
Free

For more than 102 additional continuing education articles related to cancer topics, go to NursingCenter.com/CE.

Earn CE credit online: Go to www.nursingcenter.com/CE/nursing and receive a certificate within minutes.

Back to Top | Article Outline

INSTRUCTIONS Penile cancer: Providing patient support

TEST INSTRUCTIONS

  • To take the test online, go to our secure website at www.nursingcenter.com/ce/nursing. View instructions for taking the test online there.
  • If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form on page 40. You may make copies of the form. Each question has only one correct answer. There is no minimum passing score required.
  • Complete the registration information and course evaluation. Mail the completed form and registration fee of $12.95 to: Lippincott Professional Development, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
  • You will receive your CE certificate of earned contact hours and an answer key to review your results.
  • Registration deadline is March 6, 2020.
Back to Top | Article Outline

DISCOUNTS and CUSTOMER SERVICE

  • Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together by mail, and deduct $0.95 from the price of each test.
  • We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Back to Top | Article Outline

PROVIDER ACCREDITATION

Lippincott Professional Development will award 1.0 contact hour for this continuing nursing education activity.

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida CE Broker #50-1223. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour.

Penile cancer: Providing patient support

GENERAL PURPOSE: To provide nurses with information about cancer of the penis. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Identify signs and symptoms of penile cancer. 2. List treatment options for the patient with penile cancer. 3. Discuss nursing considerations for the patient with penile cancer.

  1. Approximately 95% of penile cancers are
    1. squamous cell carcinomas.
    2. basal cell carcinomas.
    3. melanomas.
  2. Risk factors that trigger PeIN include
    1. obesity.
    2. alcohol consumption.
    3. HPV infection.
  3. Melanomas of the penis are most often found on the
    1. glans.
    2. foreskin.
    3. urethral meatus
  4. Which penile carcinoma has a low probability of metastasizing?
    1. sarcoma
    2. basal cell
    3. melanoma
  5. Which type of SCC is found on the glans and foreskin of the penis?
    1. EQ
    2. BD
    3. BP
  6. Which of the following is characteristic of BP?
    1. It presents as a single isolated lesion.
    2. It's highly invasive.
    3. It occurs more often than BD in sexually active young men.
  7. A penile lesion appearing brown, blue, black, and flat with asymmetrical borders is most likely to be
    1. melanoma.
    2. basal cell carcinoma.
    3. squamous cell carcinoma.
  8. Malignancy that has grown into the corpus spongiosum or corpus cavernosa or urethra, and has spread to lymph nodes and other body parts is
    1. stage 4.
    2. stage 3B.
    3. stage 3A.
  9. Which of the following chemotherapeutic agents is commonly used for systemic treatment of metastatic penile cancer?
    1. fluorouracil
    2. cisplatin
    3. carboplatin
  10. The single greatest prognostic indicator of survival from penile cancer is
    1. patient age at diagnosis.
    2. location of the lesion.
    3. lymph node involvement.
  11. What treatment does the author specify to be curative in about 50% of patients with penile cancer who are at high risk for metastasis?
    1. systemic chemotherapy
    2. radical lymphadenectomy
    3. Mohs micrographic surgery
  12. Which procedure is most appropriate for a patient with noninvasive lesions?
    1. glansectomy
    2. total glans resurfacing
    3. partial penectomy
  13. Following a radical penectomy, the patient will be
    1. able to stand to urinate.
    2. able to ejaculate after a 4- to 8-week recovery period.
    3. placed on stool softeners.
  14. A penile malignancy confined to the epidermis is stage
    1. 0.
    2. 1.
    3. 2.
  15. Which of the following should patients receiving systemic chemotherapy report to their healthcare provider immediately?
    1. fatigue
    2. sore throat
    3. mild nausea
  16. After partial penectomy, the patient should be taught to refrain from sexual activity for
    1. 1 to 3 weeks.
    2. 4 to 8 weeks.
    3. 10 to 12 weeks.
  17. According to the American Cancer Society, with treatment, men with stage 2 penile cancer have a 5-year survival rate of
    1. 59%.
    2. 72%.
    3. 85%.
  18. The risk of cancer of the penis is mitigated by good genital hygiene, lifestyle modification, and
    1. a diet high in vitamin C.
    2. exercise.
    3. circumcision.
Figure

Figure

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.